Overactive Bladder Common in Postacute COVID-19 Syndrome
WEDNESDAY, Nov. 30, 2022 (HealthDay News) — Overactive bladder (OAB) symptoms are common in patients recovering from postacute COVID-19 syndrome (PACS), according to a study published online Oct. 26 in the Journal of Multidisciplinary Healthcare.Atha…
Learn MoreSecond Death in Trial of Experimental Alzheimer Drug Raising Concerns
TUESDAY, Nov. 29, 2022 (HealthDay News) — Two people have now died from brain hemorrhages that may be linked to an experimental drug for Alzheimer disease, calling into question the medication’s safety.A 65-year-old woman with early-stage Alzheimer d…
Learn MoreHigh Sugar Consumption Affects Aging in Childhood Cancer Survivors
MONDAY, Nov. 28, 2022 (HealthDay News) — Survivors of childhood cancer who consume more sugar have a greater number of aging-related health conditions, according to a study presented at the American Association for Cancer Research Special Conference:…
Learn MoreLead Toxin Concerns Spur Recall of Toddler Sippy Cups
MONDAY, Nov. 28, 2022 (HealthDay News) — Parents whose toddlers use certain Green Sprouts bottles or cups need to discard them immediately because of a risk for lead exposure, the U.S. Consumer Product Safety Commission (CPSC) warns. When the base of…
Learn MoreNew COVID-19 Variant XBB Gaining Ground Among Americans
MONDAY, Nov. 28, 2022 (HealthDay News) — U.S. health officials are tracking a new COVID-19 variant that is a combination of two earlier omicron subvariants. Known as XBB, this latest subvariant now represents 3.1 percent of new COVID-19 cases through…
Learn MoreMonkeypox Renamed Mpox Amid Racism Concerns
MONDAY, Nov. 28, 2022 (HealthDay News) — Monkeypox still exists, but its name is being phased out over racism concerns.For the next year, the terms monkeypox and the new name mpox will be used interchangeably before the virus is permanently renamed m…
Learn MoreFDA Approves First Gene Therapy for Adults With Hemophilia B
MONDAY, Nov. 28, 2022 (HealthDay News) — The U.S. Food and Drug Administration has approved Hemgenix (etranacogene dezaparvovec) for the treatment of hemophilia B in adults.Hemgenix, an adeno-associated virus vector-based gene therapy, is administere…
Learn MoreCervical Cancer Incidence Up Among Women Ages 30 to 34 Years
MONDAY, Nov. 28, 2022 (HealthDay News) — Between 2001 and 2019, cervical cancer incidence declined or remained stable among U.S. women except for those in the 30- to 34-year-old age group, according to a research letter published online Nov. 21 in th…
Learn MoreBenzodiazepines Tied to Drug Overdose in Young People With Sleep Disorders
MONDAY, Nov. 28, 2022 (HealthDay News) — Benzodiazepines are associated with an increased risk for drug overdose among young people versus alternative pharmacologic treatments for common sleep disorders, according to a study published online Nov. 22 …
Learn MoreE-Cigarettes, Vaping Tied to Higher Cavity Risk
MONDAY, Nov. 28, 2022 (HealthDay News) — Electronic cigarette or vaping users have a higher risk for developing dental caries, according to a study published in the December issue of the Journal of the American Dental Association.Karina F. Irusa, fro…
Learn More
English
Spanish